KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to -$397.0 million.

  • Bausch Health Companies' Net Cash Flow fell 448.25% to -$397.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.0 million, marking a year-over-year increase of 1289.58%. This contributed to the annual value of $275.0 million for FY2024, which is 24.03% down from last year.
  • Latest data reveals that Bausch Health Companies reported Net Cash Flow of -$397.0 million as of Q3 2025, which was down 172.58% from $547.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Net Cash Flow registered a high of $547.0 million during Q2 2025, and its lowest value of -$1.4 billion during Q3 2022.
  • For the 3-year period, Bausch Health Companies' Net Cash Flow averaged around $65.6 million, with its median value being $56.0 million (2023).
  • Its Net Cash Flow has fluctuated over the past 5 years, first slumped by 26,940.00% in 2022, then spiked by 544.72% in 2025.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Net Cash Flow stood at $219.0 million in 2021, then slumped by 71.23% to $63.0 million in 2022, then skyrocketed by 158.73% to $163.0 million in 2023, then soared by 198.16% to $486.0 million in 2024, then slumped by 448.25% to -$397.0 million in 2025.
  • Its Net Cash Flow stands at -$397.0 million for Q3 2025, versus $547.0 million for Q2 2025 and -$65.0 million for Q1 2025.